PROLOR Biotech, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/13 Q2

ended 03/31/13 Q1

ended 12/31/12 FY 2012

ended 09/30/12 Q3

ended 06/30/12 Q2

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Updated info for already-effective prospectus

Removal from listing

Ownership Filter

Frost Phillip MD Et Al

Hsiao Jane Ph D

News Filter

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

TO PRESENT POSITIVE RESULTS FROM PRECLINICAL STUDIES of LONG-ACTING CLOTTING FACTOR Vlla-Ctp AT ISTH 2013

Material Disclosure, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Initiates Pivotal Phase III Trial of Its Longer-Acting Version of Human Growth Hormone

Proxies Filter

Proxy related to merger

Preliminary revised proxy

Preliminary revised proxy

Preliminary proxy related to merger

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Certification of approval for listing on the NYSE